[Research progress of histone 3 methyltransferase MLL4].


Journal

Sheng li xue bao : [Acta physiologica Sinica]
ISSN: 0371-0874
Titre abrégé: Sheng Li Xue Bao
Pays: China
ID NLM: 20730130R

Informations de publication

Date de publication:
25 Aug 2019
Historique:
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 27 9 2019
Statut: ppublish

Résumé

Mixed linked leukemia 4 (MLL4) is a specific methyltransferase of histone 3 position lysine 4 (H3K4). It is also one of the important members of COMPASS/Set1-like protein complex. Both MLL4 protein itself and its mediated H3K4 methylation modification can cause changes in chromatin structure and function, thus regulating gene transcription and expression. With the studies of MLL4 protein in recent years, the roles of MLL4 gene, MLL4 protein and protein complex in the development of tissues and organs, tumor diseases and other physiological and pathophysiological processes have been gradually revealed. In this paper, the research progress of MLL4 gene, MLL4 protein characteristics, biological function and its effect on disease were reviewed, in order to further understand the effect of histone methyltransferase on gene expression regulation, as well as its non-enzyme dependent function. This paper may provide new ideas for the prevention, diagnosis and treatment of related diseases.

Identifiants

pubmed: 31440761

Substances chimiques

DNA-Binding Proteins 0
Histones 0
Histone-Lysine N-Methyltransferase EC 2.1.1.43
MLL4 protein, human EC 2.1.1.43

Types de publication

Journal Article Review

Langues

chi

Sous-ensembles de citation

IM

Pagination

637-644

Auteurs

Hui-Hui Guo (HH)

Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Sheng-Feng Lu (SF)

Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Yun Cai (Y)

Key Laboratory of Acupuncture and Medicine Research of Ministry of Education, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Shu-Bao Liu (SB)

Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China.

Bing-Mei Zhu (BM)

Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China. zhubm64@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH